====== GSK343 3μM R03 exp124 ====== ==== Mechanism of Action ==== Inhibits EZH1 catalytic subunit of PRC2 histone methyltransferase (H3K27me3) * **Class / Subclass 1:** Gene Regulation / Epigenetic Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%N-[(6-Methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-propan-2-ylindazole-4-carboxamide%% * **Synonyms:** N/A * **CAS #:** 1346704-33-3 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/71268957|71268957]] * **IUPAC:** %%N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-propan-2-ylindazole-4-carboxamide%% * **INCHI Name:** InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40) * **INCHI Key:** ULNXAWLQFZMIHX-UHFFFAOYSA-N * **Molecular Weight:** 541.7 * **Canonical SMILES:** CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC(=NC=C4)N5CCN(CC5)C)C(C)C * **Isomeric SMILES:** N/A * **Molecular Formula:** C31H39N7O2 {{:chemogenomics:structures:chem-0077.svg?nolink}} * **Supplier Name:** Structural Genomics Consortium * **Catalog #:** N/A * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C31H39N7O2 542.3238; found 542.3251 * **Platform ID:** GSK343 * **Min:** -1.8961; **Max:** 98.3550 {{:chemogenomics:dose_response:dr_82.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |1.9378 | | IC30 |2.9381 | | IC40 |4.1327 | | IC50 |5.6521 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 03 * **Dose**: 3µM * **Days of incubation**: 8 * **Doublings**: 7.3 * **Numbers of reads**: 10394618 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |4/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/GSK343_3uM_Round-3_exp124.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp124.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:K:KDSR|KDSR]]|-4.49|<0.01| |[[:human_genes:T:TCF4|TCF4]]|-3.35|<0.01| |[[:human_genes:A:ADAMDEC1|ADAMDEC1]]|-2.98|<0.01| |[[:human_genes:Z:ZBTB2|ZBTB2]]|-2.95|0.02| |[[:human_genes:T:TPK1|TPK1]]|-2.43|0.32| |[[:human_genes:R:RBM14|RBM14]]|-2.35|0.32| |[[:human_genes:R:RIF1|RIF1]]|-2.32|0.32| |[[:human_genes:R:RBM14-RBM4|RBM14-RBM4]]|-2.32|0.32| |[[:human_genes:U:USP7|USP7]]|-2.23|0.32| |[[:human_genes:F:FDPS|FDPS]]|-2.20|0.33| |[[:human_genes:F:FDFT1|FDFT1]]|-2.16|0.32| |[[:human_genes:M:MCM9|MCM9]]|-2.16|0.32| |[[:human_genes:P:PEX7|PEX7]]|-2.13|0.32| |[[:human_genes:R:RPP21|RPP21]]|-2.12|0.32| |[[:human_genes:M:MVD|MVD]]|-2.09|0.33| |[[:human_genes:B:BTBD10|BTBD10]]|-2.08|0.32| |[[:human_genes:D:DNAJC9|DNAJC9]]|-2.07|0.33| |[[:human_genes:F:FGFBP2|FGFBP2]]|-2.07|0.42| |[[:human_genes:F:FLVCR1|FLVCR1]]|-2.06|0.32| |[[:human_genes:C:C21orf58|C21orf58]]|-2.06|0.33| |[[:human_genes:C:CXorf58|CXorf58]]|-2.04|0.32| |[[:human_genes:R:RPS17L|RPS17L]]|-2.02|0.63| |[[:human_genes:B:BRWD1|BRWD1]]|-2.02|0.32| |[[:human_genes:F:FBXW7|FBXW7]]|-2.02|0.42| |[[:human_genes:P:PRKCDBP|PRKCDBP]]|-2.01|0.32| |[[:human_genes:I:IQGAP2|IQGAP2]]|-2.01|0.32| |[[:human_genes:C:C16orf62|C16orf62]]|-2.00|0.32| |[[:human_genes:G:GPR107|GPR107]]|-2.00|0.32| |[[:human_genes:M:MTMR4|MTMR4]]|-1.99|0.32| |[[:human_genes:C:CTSK|CTSK]]|-1.99|0.32| |[[:human_genes:S:SLC5A11|SLC5A11]]|1.93|0.81| |[[:human_genes:A:AFF1|AFF1]]|1.93|0.81| |[[:human_genes:L:LCE3C|LCE3C]]|1.94|0.81| |[[:human_genes:H:HEPHL1|HEPHL1]]|1.94|0.81| |[[:human_genes:C:CTTNBP2|CTTNBP2]]|1.94|0.81| |[[:human_genes:C:CPSF6|CPSF6]]|1.95|0.81| |[[:human_genes:C:CD47|CD47]]|1.97|0.81| |[[:human_genes:N:NPRL3|NPRL3]]|2.00|0.81| |[[:human_genes:B:BBIP1|BBIP1]]|2.00|0.81| |[[:human_genes:N:NOL9|NOL9]]|2.01|0.81| |[[:human_genes:I:ITGAX|ITGAX]]|2.02|0.81| |[[:human_genes:P:PZP|PZP]]|2.05|0.81| |[[:human_genes:C:CDK1|CDK1]]|2.05|0.81| |[[:human_genes:A:ASB11|ASB11]]|2.06|0.81| |[[:human_genes:P:POLD3|POLD3]]|2.09|0.81| |[[:human_genes:T:TBC1D3I|TBC1D3I]]|2.12|0.81| |[[:human_genes:T:TBC1D3E|TBC1D3E]]|2.12|0.81| |[[:human_genes:T:TBC1D3K|TBC1D3K]]|2.13|0.81| |[[:human_genes:T:TBC1D3L|TBC1D3L]]|2.13|0.81| |[[:human_genes:X:XPO4|XPO4]]|2.15|0.81| |[[:human_genes:S:SCAF11|SCAF11]]|2.15|0.81| |[[:human_genes:A:ANKHD1-EIF4EBP3|ANKHD1-EIF4EBP3]]|2.23|0.81| |[[:human_genes:P:PRPF19|PRPF19]]|2.24|0.81| |[[:human_genes:N:NOP16|NOP16]]|2.25|0.81| |[[:human_genes:N:NUP88|NUP88]]|2.29|0.81| |[[:human_genes:A:APBA1|APBA1]]|2.37|0.81| |[[:human_genes:E:EIF3B|EIF3B]]|2.38|0.81| |[[:human_genes:R:RPL30|RPL30]]|2.42|0.81| |[[:human_genes:Z:ZFP82|ZFP82]]|2.46|0.47| |[[:human_genes:A:ATP6V0B|ATP6V0B]]|2.70|0.81| ^Screen^Correlation^Plot^ |[[:results:exp151|SGC0946 7μM R03 exp151]]|0.084|| |[[:results:exp155|UNC1999 2μM R03 exp155]]|0.076|| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|0.067|| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|0.06|| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|0.053|| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|0.052|| |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|0.052|| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|0.056|| {{:chemogenomics:comparison_plots:exp124_vs_exp151.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp155.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp508.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp530.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp442.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp185.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp348.png?nolink |}} No GO term hits below threshold. (FDR <0.05) No GO term hits below threshold. (FDR <0.05)